China's State FDA Steps Up Transparency With First Annual Review Of Drug Approval Process, Outcome

BEIJING - In a step toward lifting a longstanding veil on the drug review process in China, the State FDA has for the first time issued a public outline of the range and types of medicines approved by regulators last year